The stock market indices had a volatile session, with four different, separate swings, but by the end of the day they rallied back in the afternoon in beautiful, 5-wave advance from the midsession pullback low to close near the session highs with positive gains on the day.

Net on the day, the Dow, which was as much as 100 points down, closed up 14.57 at 17,230.54. The S&P 500 was up 1.54 to 2003.70, 1 point off its high. The Nasdaq 100 was up 23.44 to 4462.0742, 42 points off its high.

Advance-declines were 18 to 13 negative on New York Stock Exchange and nearly 2 to 1 positive on Nasdaq. Up/down volume was 2 to 1 positive on New York, with total volume of 3.15 billion shares. Nasdaq traded 1.5 billion shares, and had a 2 to 1 positive volume ratio.

TheTechTrader.com board was mixed, but a lot of the Nasdaq generals that we follow did well. Priceline Inc. (PCLN), approaching all-time highs, was up 39.56 to 1376.13, Google Inc. (GOOG) up 3.90 to 666.10, Apple Inc. (AAPL) up on 69 cents to 111.73, Amazon.com Inc. (AMZN) 2.39 to 573.15, and Netflix, Inc. (NFLX) 2.70 to 101.69.

Tesla Motors, Inc. (TSLA) jumped 1.09 to 228.10.

GoPro, Inc. (GPRO) was up, reaching its high early in the day, then stair-stepped its way down early afternoon, and then ran back up, closing up 1.12 to 29.64 near the end of the day.

On the downside, many biotech stocks had a rough session. Radius Health, Inc. (RDUS) lost 5.84 to 63.09, and Heron Therapeutics, Inc. (HRTX) dropped 1.17 to 22.57, but most biotech's we follow actually closed near afternoon-rally highs.

SolarCity Corporation (SCTY), on downgrades, was down 2.88 to 41.28.

Checking the TheTechTrader.com percent-gain leaderboard, Northwest Biotherapeutics, Inc. (NWBO) bounced 63 cents to 4.82, or 15%, on 2 million shares. Adaptimmune Therapeutics (ADAP) closed up 92 cents to 8.20, or 13%, on 1 million shares. Keryx Biopharmaceuticals Inc. (KERX) popped 53 cents to 4.85, or 12%, on 7.4 million shares.

Kandi Technologies Group, Inc. (KNDI), the automotive stock, climbed 1.45 to 9.23, or 19%, on 1.6 million shares.

By far, the winner of the day was Weight Watchers International, Inc. (WTW), after Oprah bought into the company for 10%, the stock exploded by 105%, up 7.13 to 13.92, on 71 million shares. It traded to over 15.00 at one point in the day. FibroGen, Inc. (FGEN) gained 3.60 to 25.47, or 16 1/2%.

Among other gainers, MacroGenics, Inc. (MGNX) bounced 3.27 to 29.28, and Zafgen, Inc. (ZFGN), bouncing back from recent horrendous losses, advanced 1.13 to 11.49.

BSQUARE Corp. (BSQR) had quite a day, up 52 cents to 8.99.

Gold got hurt. The Direxion Daily Jr Gld Mnrs Bear 3X ETF (JDST) ran 3.08 to 25.90 and the Direxion Daily Gold Miners Bear 3X ETF (DUST) popped 1.54 to 14.34. They were both gainers between 12% and 14%. The VelocityShares 3x Inverse Crude Oil ETN (DWTI) advanced 6.74 to 97.97.

Stepping back and reviewing the hourly chart patterns, the indices opened down, rallied back nicely in a 3-wave advance, had a 3-wave, corrective pullback by midday, which held the morning lows, and then caused a 3-wave rally into the close not far from the session highs. Let's see how it goes tomorrow.

Good Trading!

In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.

Recommended Content


Recommended Content

Editors’ Picks

EUR/USD stabilizes near 1.0800 as trading action turns subdued

EUR/USD stabilizes near 1.0800 as trading action turns subdued

EUR/USD holds steady near 1.0800 on Thursday and remains on track to end the day in negative territory following upbeat macroeconomic data releases from the US. The action in financial markets turn subdued as trading volumes thin out heading into Easter holiday.

EUR/USD News

GBP/USD extends sideways grind above 1.2600

GBP/USD extends sideways grind above 1.2600

GBP/USD fluctuates in a narrow channel above 1.2600 on Thursday. The better-than-expected Initial Jobless Claims data from the US and the upward revision to the Q4 GDP growth help the USD stay resilient against its rivals and limits the pair's upside.

GBP/USD News

Gold pulls away from daily highs, holds above $2,200

Gold pulls away from daily highs, holds above $2,200

Gold retreats from daily highs but holds comfortably above $2,200 in the American session on Thursday. The benchmark 10-year US Treasury bond yield stays near 4.2% after upbeat US data and makes it difficult for XAU/USD to gather further bullish momentum.

Gold News

XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC

XRP price falls to $0.60 support as Ripple ruling doesn’t help Coinbase lawsuit against SEC

XRP programmatic sales ruling by Judge Torres was completely rejected by another US Court that ruled in favor of the SEC in a lawsuit against Coinbase. 

Read more

Portfolio rebalancing and reflation trades emerge into Q2

Portfolio rebalancing and reflation trades emerge into Q2

Yesterday’s price action pointed at a possible end-of-quarter portfolio rebalancing as the session saw the laggards of the quarter like Apple and Tesla gain, and the stars like Microsoft and Nvidia retreat.

Read more

Majors

Cryptocurrencies

Signatures